Otsing - TalTech teadusportaal

Publikatsioonid
Profiilid
Uurimisrühmad
Registrid
Abi ja info
Switch to English

Publikatsioonid

Publikatsioonid

Liitotsing

Valitud kirjed 0

anti-GBM disease (võtmesõna)

—

—

Lisa tingimus Lihtotsing filter

Tühista

teaviku laadid

raamat ..

artikkel ajakirjas ..

artikkel ajalehes ..

artikkel kogumikus ..

dissertatsioon ..

Open Access ..

Teaduspublikatsioon ..

aasta

Toon andmeid..

Toon andmeid..

TTÜ struktuuriüksus

Toon andmeid..

Toon andmeid..

Toon andmeid..

Toon andmeid..

Toon andmeid..

Tühista

Kirjeid leitud 3
Vaata veel.. (5/118)
Ekspordi

ekspordi kõik päringu tulemused (3)
Salvesta TXT fail

prindi
Märgitud kirjetega toimetamiseks ava valitud kirjed

kuva

reasta
1

artikkel ajakirjas EST / artikkel ajakirjas ENG

Endopeptidase cleavage of anti-glomerular basement membrane antibodies in vivo in severe kidney disease : an open-label phase 2a studyUhlin, Nils Fredrik Arne; Szpirt, Wladimir; Kronbichler, Andreas; Bruchfeld, Annette; Soveri, Inga; Rostaing, Lionel; Daugas, Eric; Lionet, Arnaud; Kamar, Nassim; Rafat, CedricJournal of the American Society of Nephrology2022 / p. 829-838 https://doi.org/10.1681/ASN.2021111460 Journal metrics at Scopus Article at Scopus Journal metrics at WOS Article at WOS

artikkel ajakirjas EST / artikkel ajakirjas ENG
2

artikkel ajakirjas EST / artikkel ajakirjas ENG

The IgG-degrading enzyme of Streptococcus pyogenes causes rapid clearance of anti-glomerular basement membrane antibodies in patients with refractory anti-glomerular basement membrane diseaseSoveri, Inga; Molne, Johan; Uhlin, Nils Fredrik Arne; Nilsson, Thomas; Kjellman, Christian; Sonessonm, Elisabeth; Segelmark, MartenKidney International2019 / p. 1234-1238 https://doi.org/10.1016/j.kint.2019.06.019 Journal metrics at Scopus Article at Scopus Journal metrics at WOS Article at WOS

artikkel ajakirjas EST / artikkel ajakirjas ENG
3

artikkel ajakirjas EST / artikkel ajakirjas ENG

Using imlifidase to elucidate the characteristics and importance of anti-GBM antibodies produced after start of treatmentTyrberg, Linnea; Andersson, Fanny; Uhlin, Nils Fredrik Arne; Hellmark, Thomas; Segelmark, MartenNephrology Dialysis Transplantation2024 / p. 45-54 https://doi.org/10.1093/ndt/gfad132 Journal metrics at Scopus Article at Scopus Journal metrics at WOS Article at WOS

artikkel ajakirjas EST / artikkel ajakirjas ENG

Kirjeid leitud 3, kuvan 1 - 3

1. anti-GBM disease
2. Alzheimer’s disease
3. Alzheimer's disease
4. atherosclerotic cardiovascular disease (ASCVD)
5. autoantibody-mediated renal disease
6. autosomal dominant polycystic kidney disease
7. cardiovascular disease
8. celiac disease
9. cerebrovascular disease
10. chronic kidney disease
11. chronic kidney disease (CKD)
12. chronic obstructive pulmonary disease
13. coronary artery disease
14. coronary artery disease (CAD)
15. coronary disease
16. coronary heart disease
17. disease
18. disease diagnosis
19. disease model
20. disease models
21. disease progression
22. disease resistance
23. disease-modifying therapy
24. End stage kidney disease
25. end stage renal disease
26. end-stage kidney disease
27. end-stage renal disease
28. garment workers and patients with occupational disease
29. gas bubble disease
30. genetic predisposition to disease
31. heart disease risk factors
32. human disease
33. Huntington’s disease
34. infectious disease
35. in-transit disease
36. late blight disease
37. loco-regionally metastatic disease
38. lyme disease
39. mechanisms of disease
40. Menkes disease
41. Metabolic dysfunction-associated steatotic liver disease
42. molecular bases of disease
43. NAFLD (non-alcoholic fatty liver disease)
44. neurodegenerative disease
45. neuromuscular disease
46. non-alcoholic fatty liver disease
47. oat striate and red disease
48. Parkinson disease
49. Parkinson’s disease
50. Parkinson’s disease machine learning
51. Parkinson's disease
52. physical overload disease
53. preclinical Alzheimer disease
54. renal disease
55. shell disease
56. stable coronary heart disease
57. stereotypy of disease
58. subclinical cardiovascular disease
59. Wilson disease
60. Wilson’s disease
61. von Willebrand disease
62. anti‐A
63. anti-abuse
64. anti-abuse rule
65. anti-armor mine
66. anti‐B
67. anti-bacterial agents
68. anti-CD20 monoclonal antibodies
69. anti-competitive agreement
70. anti-H1N1 antibodies
71. anti-lock braking system
72. anti–lock braking system
73. anti-money laundering
74. anti-money laundering (AML)
75. anti-monotonicity
76. Anti-Muslim prejudice
77. anti-oxidant content
78. anti-oxidative activity
79. anti-P2X4 mAb
80. anti-quorum sensing
81. anti-spoofing
82. Anti-Str. uberis antibodies
83. Anti-TrustRank
84. general anti-abuse rule

1. Alber, Anti
2. Allikvee, Anti
3. Gruno, Anti
4. Haavajõe, Anti
5. Hamburg, Anti
6. Kalda, Anti
7. Kuiv, Anti
8. Kukkela, Anti
9. Kuus, Anti
10. Liiv, Anti
11. Liiva, Anti
12. Look, Anti
13. Naulainen, Anti
14. Palmi, Anti
15. Rohumaa, Anti
16. Ronk, Anti
17. Saar, Anti
18. Sullin, Anti
19. Viikna, Anti

1. Haavajõe, Anti
2. Hamburg, Anti
3. Hamburg, Anti, 1983-
4. Haugas, Anti
5. Kuiv, Anti
6. Perkson, Anti
7. Puusepp, Anti, 1969-
8. Siinmaa, Anti
9. Viikna, Anti, 1944-2023

1. Alber, Anti
2. Haavajõe, Anti
3. Hamburg, Anti
4. Rohumaa, Anti
5. Viikna, Anti 1944-2023

1. European Anti-Fraud Office

vaste

reasta

Otsing
Valikud 0

ilmumisaasta

autor

TTÜ struktuuriüksus

märksõna

seeria-sari

tema kohta

võtmesõna

TalTech Raamatukogu

Akadeemia tee 1

13519

TalTech koduleht TalTech Raamatukogu koduleht Digikogu Digiteek Teadusandmed

6203551

data@taltech.ee

TalTech Raamatukogu